Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From Apr 09, 2025

Specialty Chemical Q4 Results Preview: Sustained Pricing Pressure To Weigh On Margin Recovery, Says DRChoksey

Specialty Chemical Q4 Results Preview: Sustained Pricing Pressure To Weigh On Margin Recovery, Says DRChoksey
Based on the growth drivers, DRChoksey's top picks are UPL, supported by strong volume growth and gradual recovery in price, and Ami Organics, with strong growth in the Advanced Intermediates segment. (Photo Source: freepik).
STOCKS IN THIS STORY
Tatva Chintan Pharma Chem Ltd
--
Gujarat Fluorochemicals Ltd.
--
Supreme Petrochem Ltd.
--
Navin Fluorine International Ltd.
--
Anupam Rasayan India Ltd
--
Laxmi Organic Industries Ltd
--
Archean Chemical Industries Ltd
--
Rossari Biotech Ltd.
--
Fineotex Chemical Ltd.
--
UPL Ltd.
--
Balaji Amines Ltd.
--
Ami Organics Ltd
--
Vinati Organics Ltd.
--

In Q4 FY25E, the brokerage anticipate that revenue growth for most companies will be driven primarily by higher volumes, with limited margin expansion owing to continued competitive pricing pressure. While prices across a broad range of specialty chemicals appear to have stabilized, a sustained upward trend is yet to materialize.

NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.

DRChoksey Report

In Q4 FY25E, we expect double-digit YoY revenue growth from the specialty chemical companies in our coverage. The revenue is expected to grow 24.8% YoY (+29.0% QoQ) driven by strong volume growth, capacity additions and reducing dependency on the agrochemical sector.

We expect positive YoY revenue growth from the entire coverage companies (barring Balaji Amines). Notable companies are Ami Organics (strong growth in the Advanced Intermediates segment), Navin Fluorine (new capacities coming in from R32 and Specialty Chemicals) and Anupam Rasayan (driven by strong growth in the pharma and polymer segments).

Ebitda is expected to grow at a similar pace to revenue growth at 27.0% YoY (+28.0% QoQ). Ebitda margins are expected to expand 32 bps YoY (-14 bps QoQ) due to an unfavorable product mix, pricing pressure and weak realization.

Ebitda margin is expected to contract for half of the coverage companies, where Balaji Amines and Tatva Chintan are expected to post weak margin growth among our coverage due to persistent market headwinds impacting pricing and continued struggle in the SDA segment, respectively.

Click on the attachment to read the full report:

Deven Choksey Research Specialty Chemical Sector Earnings Preview_Q4FY25E.pdf
VIEW DOCUMENT

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

To continue reading this story
You must be an existing Premium User

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search